SignaBlok Receives Orphan Drug Designation from FDA for TREM-1 inhibitor for the Treatment of Retinopathy of Prematurity

FDA grants Orphan Drug Designation to SignaBlok's first-in-class, new mechanism-based TREM-1 peptide inhibitor to treat ...
pharmaphorum

Corcept gets FDA OK for first-in-class ovarian cancer drug

Almost four months ahead of schedule, Corcept Therapeutics' selective glucocorticoid receptor antagonist (SGRA) relacorilant ...
Yahoo

FDA approves 1st new class of opioid-free painkillers in over 20 years

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) has greenlit a new type of pain medication for the first time in more than 20 years. What's ...
Pharmaceutical Technology on MSN

Corcept’s first-in-class ovarian cancer drug gains FDA approval

The drug can now be prescribed alongside nab-paclitaxel for patients with ovarian cancer who have relapsed between one and three times.
MobiHealthNews

uChek app is currently FDA registered as Class I device

Following MobiHealthNews' coverage of the rare action that FDA took last week by sending a medical app developer an "It has come to our attention" letter that instructs it to seek 510(k) clearance for ...
Frontiers

Differential drug responsiveness in addiction: Multivariate determinants across psychostimulants and opioids

Not all drug users are the same. To understand different profiles of patients that use addictive substances, research frameworks typically classify cases by ...